Cardiomyocytes Differentiation (Ventricular & Atrial)

We provide top-quality service for the directed differentiation of iPSCs into cardiomyocytes using our efficient induction protocol and reagents. We deliver ready-to-use, functional ventricular and atrial cardiomyocytes that are desirable in vitro models for high-content toxicity and drug screening, and cell regeneration research. We deliver receive feasible and physiologically relevant alternatives to embryonic stem cells, primary cells, and animal models. 

• High-quality atrial and ventricular cardiomyocytes
• Biomarkers:
  • cTNT, alpha-SMA, MLC2A, and MLC2V; video of beating cells
    
• We can generate differentiated cardiomyocytes from iPSC derived from healthy or disease patient samples
• Fast turnaround: 2 weeks
• GMP iPSC Differentiation Services Available >> Learn More 

Get iPSCs to genetically modify and further differentiate into immune cells? We offer fully customizable iPSC generation from human or non-human tissue samples, and our genome editing experts can use CRISPR or TARGATT™  to genetically alter the iPSCs to fit your project requirements. If you need to expedite your experimental timeline, ASC also offers off-the-shelf cardiomyocytes. Contact us today to find the best solution for your projects.

Beating iPSC-Derived Cardiomyocytes - Video 1| Applied StemCell, Inc.

Beating iPSC-Derived Cardiomyocytes - Video 2 | Applied StemCell, Inc.